Thingsfactory introduces new technology for fever and behaviour detection in Livestock

    NEXT STORY
    Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer
    PREV STORY
    Brandywine Realty Trust Announces Tax Characteristics of Its 2020 Distributions
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Advances in Treating Non-Small Cell Lung Cancer

    author_avatar
    NASDAQ Market News

    Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences

    author_avatar
    NASDAQ Market News

    Axsome Therapeutics to Host R&D Day with Key Opinion Leaders Focused on AXS-05 and Unmet Needs in Depression, Alzheimer’s Disease Agitation, and Nicotine Dependence

    NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage ...

    author_avatar
    NASDAQ Market News